SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-029474
Filing Date
2017-05-02
Accepted
2017-05-02 21:07:20
Documents
2
Period of Report
2017-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4312
2 POA DOCUMENT poa.txt EX-24.4_720805 4024
  Complete submission text file 0001209191-17-029474.txt   9934
Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address
OLANOFF LAWRENCE S (Reporting) CIK: 0001224341 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 17806950

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations